Showing 1 - 20 results of 7,359 for search '(( significant ((genes decrease) OR (mean decrease)) ) OR ( significantly better decrease ))', query time: 0.52s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Top 10 significant functional annotations of up-regulated DEGs. by Meitner Cadena (22216261)

    Published 2025
    “…Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”
  8. 8

    Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

    Published 2025
    “…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”
  9. 9
  10. 10

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
  11. 11
  12. 12
  13. 13
  14. 14

    Loxoprofen and SB225002 administration decreased sound stress exposure-induced hyperalgesia. by Satoka Kasai (3861115)

    Published 2025
    “…Mice treated with loxoprofen (500 mg/kg) or SB225002 (3 mg/kg) showed significantly decreased response times to the filament compared to Stress + saline group (Stress + loxoprofen (500 mg/kg), 30 min after administration, **<i>P</i> < 0.01, 60 min after administration, ***<i>P</i><i> <i><</i> </i>0.001; Stress + SB225002 (3 mg/kg), 60 min after administration, *<i>P</i> < 0.05). 2-way ANOVA <i>post-hoc</i> Bonferroni test. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”